Indraprastha Medical Corporation Ltd Share Price

(INDRAMEDCO)

Indraprastha Medical Corporation (IMCL) was incorporated as a public company in 1988 and provides high quality and cost-effective hospital services. They came out with a public issue of 22,918,300 equity shares of Rs. 10 each in 1988. IMCL set up a multidisciplinary tertiary care referral hospital in Delhi in 1998-99 with a stroke unit and 6 operations theatres. In 2000, they signed MOUs with the Governments of Tanzania and Mauritius and established a PUVA-UV therapy unit for skin conditions. In 2001, a satellite clinic was opened for patient consultations and samples referral. Also in 2001, a four-digit emergency number 1066 was installed - the first of its kind in the country. In 2009-10, the hospital added endoscopic ultrasonography (EUS), multi-organ transplant unit, renovated OPDs, and new orthopaedic operation theatre. In 2011, the expansion project was completed adding 127 additional beds and a Cosmetic Centre. In 2012, a robotic surgery centre and Apollo Obesity & Metabolic Surgery Bariatric centre was set up. Renal transplants were conducted in 2013-14 and a Pain Clinic was made in 2014. The Expansion Project of the main Hospital to add 127 additional Beds was completed in 2012-13. In 2019-2020, facilities like Bone Marrow Transplant Unit, 25-bed Dialysis Unit, renovated Orthopaedic operating theatre and Radiology Unit, were added. In 2021-22, a dedicated wing for Bone Marrow Transplant Unit was created. IMCL has constantly upgraded and renovated facilities in the hospital to increase patient comfort and operational efficiency over the years.

Share Price: ₹410.50 per share as on 20 Feb, 2025 04:01 PM
Market Capitalisation: ₹3,692.59Cr as of today
Listing date: 17 Apr, 1997
Chairperson Name: Jasmine Shah